Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Therapy of Herpes Simplex Encephalitis With Valacyclovir
NCT00031486Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2000
- Primary completion
- Jun 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
A Phase 3 trial of valaciclovir in herpes simplex encephalitis (HSE), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2000; status: completed.
02
Drugs
valaciclovir
03
Conditions
herpes simplex encephalitis (HSE)
Beyond the preview
Go deeper on NCT00031486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031486.